Cardiac diseases - Revision history

Agnivesha at 09:37, 24 February 2024

2024-02-24T09:37:50Z

← Older revision		Revision as of 09:37, 24 February 2024
Line 19:		Line 19:

	\|label3 = Reviewer		\|label3 = Reviewer
	\|data3 = Basisht G.<sup>2</sup>		\|data3 = [[Gopal Basisht\|Basisht G.]]<sup>2</sup>

	\|label4 = Editors		\|label4 = Editors
	\|data4 = Deole Y.S.<sup>2</sup>, Aneesh E.G.<sup>2</sup>, Basisht G. <sup>2</sup>		\|data4 = [[Yogesh Deole\|Deole Y.S.]]<sup>2</sup>, Aneesh E.G.<sup>2</sup>, [[Gopal Basisht\|Basisht G.]]<sup>2</sup>

	\|label5 = Affiliations		\|label5 = Affiliations

Agnivesha at 13:21, 6 March 2023

2023-03-06T13:21:53Z

← Older revision		Revision as of 13:21, 6 March 2023
Line 41:		Line 41:
	\|data9 = 10.47468/CSNE.2021.e01.s09.062		\|data9 = 10.47468/CSNE.2021.e01.s09.062
	}}		}}

	'''Updates on management of cardiac diseases through Ayurveda'''		'''Updates on management of cardiac diseases through Ayurveda'''
			<p style='text-align:justify;'>
	This article is based on lecture delivered by Dr. Rohit Sane in Prof.M.S.Baghel Memorial Lecture Series on June 09, 2021. The video lecture can be accessed on the link of [https://fb.watch/8l7PEmmWxC/ facebook page.]		This article is based on lecture delivered by Dr. Rohit Sane in Prof.M.S.Baghel Memorial Lecture Series on June 09, 2021. The video lecture can be accessed on the link of [https://fb.watch/8l7PEmmWxC/ facebook page.]
	<~~div style='text-align:justify;'~~>		<br/>

	The major chronic diseases prevailing in India are cardiovascular disorders (CVD), diabetes, hypertension, obesity and dyslipidemia. Mortality due to cardiovascular disease is increasing substantially. In the year 1990, the mortality rate due to CVD in India was 15.2, which increased to 28.1 in 2016.<ref>India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016.Lancet Glob Health 2018; 6: e1339–51 Available from https://www.thelancet.com/action/showPdf?pii=S2214-109X%2818%2930407-8 cited on 23/06/2021 </ref> Despite the advancements in modern medicine, especially in treating CVD like angioplasty, bypass surgery, etc., the disease burden is increasing. [[Ayurveda]] can play a significant role in treating CVD as a lifestyle disorder and a non-communicable disorder.		The major chronic diseases prevailing in India are cardiovascular disorders (CVD), diabetes, hypertension, obesity and dyslipidemia. Mortality due to cardiovascular disease is increasing substantially. In the year 1990, the mortality rate due to CVD in India was 15.2, which increased to 28.1 in 2016.<ref>India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016.Lancet Glob Health 2018; 6: e1339–51 Available from https://www.thelancet.com/action/showPdf?pii=S2214-109X%2818%2930407-8 cited on 23/06/2021 </ref> Despite the advancements in modern medicine, especially in treating CVD like angioplasty, bypass surgery, etc., the disease burden is increasing. [[Ayurveda]] can play a significant role in treating CVD as a lifestyle disorder and a non-communicable disorder.
			<br/>
	The risk factors of CVD are diabetes, hypertension, and obesity. The burden of these lifestyle disorders is also high on the rise. As per the data available, 9.7% of the adult population in India has Diabetes.<ref>Akhtar SN, Dhillon P. Prevalence of diagnosed diabetes and associated risk factors: Evidence from the large-scale surveys in India. J Soc Health Diabetes [serial online] 2017 [cited 2017 Oct 15 ];5:28-36</ref> Hypertension is present in 25% of urban and 10% of rural subjects in India. Stage I hypertension carries significant cardiovascular risk.<ref>Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004 Feb;18(2):73-8. doi: 10.1038/sj.jhh.1001633. PMID: 14730320.</ref> Therefore, it is essential to treat these comorbid conditions while treating CVD.		The risk factors of CVD are diabetes, hypertension, and obesity. The burden of these lifestyle disorders is also high on the rise. As per the data available, 9.7% of the adult population in India has Diabetes.<ref>Akhtar SN, Dhillon P. Prevalence of diagnosed diabetes and associated risk factors: Evidence from the large-scale surveys in India. J Soc Health Diabetes [serial online] 2017 [cited 2017 Oct 15 ];5:28-36</ref> Hypertension is present in 25% of urban and 10% of rural subjects in India. Stage I hypertension carries significant cardiovascular risk.<ref>Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004 Feb;18(2):73-8. doi: 10.1038/sj.jhh.1001633. PMID: 14730320.</ref> Therefore, it is essential to treat these comorbid conditions while treating CVD. </p>

	==Importance of animal trials==		==Importance of animal trials==

Agnivesha at 04:50, 21 September 2022

2022-09-21T04:50:03Z

← Older revision		Revision as of 04:50, 21 September 2022
Line 1:		Line 1:
			{{CiteButton}}
	{{#seo:		{{#seo:
	\|title=Cardiac diseases		\|title=Cardiac diseases

Eganeesh at 10:16, 15 June 2022

2022-06-15T10:16:46Z

← Older revision		Revision as of 10:16, 15 June 2022
Line 31:		Line 31:
	\|data6 = carakasamhita@gmail.com		\|data6 = carakasamhita@gmail.com

	\|label7 = ~~Date of first publication:~~		\|label7 = Publisher
	\|data7 = ~~June 26~~, ~~2021~~		\|data7 = [[Charak Samhita Research, Training and Development Centre]], I.T.R.A., Jamnagar, India

	\|label8 = DOI		\|label8 = Date of first publication:
	\|~~data8~~ = 10.47468/CSNE.2021.e01.s09.062		\|data8 = June 26, 2021

			\|label9 = DOI
			\|data9 = 10.47468/CSNE.2021.e01.s09.062
	}}		}}

Eganeesh at 11:19, 14 June 2022

2022-06-14T11:19:07Z

← Older revision		Revision as of 11:19, 14 June 2022
Line 35:		Line 35:

	\|label8 = DOI		\|label8 = DOI
	\|data8 = ~~Under process~~		\|data8 = 10.47468/CSNE.2021.e01.s09.062
	}}		}}

Agnivesha at 07:50, 30 September 2021

2021-09-30T07:50:17Z

← Older revision		Revision as of 07:50, 30 September 2021
Line 40:		Line 40:
	'''Updates on management of cardiac diseases through Ayurveda'''		'''Updates on management of cardiac diseases through Ayurveda'''

	(This article is based on lecture delivered by Dr. Rohit Sane in Prof.M.S.Baghel Memorial Lecture Series on June 09, 2021. The video lecture can be accessed on the link of [https://fb.watch/8l7PEmmWxC/ facebook page])		This article is based on lecture delivered by Dr. Rohit Sane in Prof.M.S.Baghel Memorial Lecture Series on June 09, 2021. The video lecture can be accessed on the link of [https://fb.watch/8l7PEmmWxC/ facebook page.]
	<div style='text-align:justify;'>		<div style='text-align:justify;'>

Agnivesha at 07:26, 30 September 2021

2021-09-30T07:26:42Z

← Older revision		Revision as of 07:26, 30 September 2021
Line 40:		Line 40:
	'''Updates on management of cardiac diseases through Ayurveda'''		'''Updates on management of cardiac diseases through Ayurveda'''

	(This article is based on lecture delivered by Dr. Rohit Sane in Prof.M.S.Baghel Memorial Lecture Series on June 09, 2021.)		(This article is based on lecture delivered by Dr. Rohit Sane in Prof.M.S.Baghel Memorial Lecture Series on June 09, 2021. The video lecture can be accessed on the link of [https://fb.watch/8l7PEmmWxC/ facebook page])
	<div style='text-align:justify;'>		<div style='text-align:justify;'>

Line 187:		Line 187:
	'''Ans''': [[Prakriti]] and the involvement of [[dosha]] are very much influencing the development of cardiac disorders. Typical presentations explained for different kinds of hridroga (cardiac disorders) can be seen in patients. For eg. In vataja hridroga the pain will be severe. It may be cutting, stabbing, tearing etc., in nature. In kaphaja hridrog pain will be minimal. The other symptoms like excessive salivation, heaviness in the chest etc., are more predominant. In pittaja hridroga burning in the sternum/epigastric region is the main presenting feature. The classical treatments mentioned for these individual types of cardiac disorders give an excellent result.		'''Ans''': [[Prakriti]] and the involvement of [[dosha]] are very much influencing the development of cardiac disorders. Typical presentations explained for different kinds of hridroga (cardiac disorders) can be seen in patients. For eg. In vataja hridroga the pain will be severe. It may be cutting, stabbing, tearing etc., in nature. In kaphaja hridrog pain will be minimal. The other symptoms like excessive salivation, heaviness in the chest etc., are more predominant. In pittaja hridroga burning in the sternum/epigastric region is the main presenting feature. The classical treatments mentioned for these individual types of cardiac disorders give an excellent result.
	</div>		</div>

			<big>'''Link to video lecture: https://fb.watch/8l7PEmmWxC/'''</big>

	<big>'''[[Special:ContactMe\|Send us your suggestions and feedback on this page.]]'''</big>		<big>'''[[Special:ContactMe\|Send us your suggestions and feedback on this page.]]'''</big>

Eganeesh: /* Interactive session */

2021-09-24T00:31:03Z

Interactive session

← Older revision		Revision as of 00:31, 24 September 2021
Line 187:		Line 187:
	'''Ans''': [[Prakriti]] and the involvement of [[dosha]] are very much influencing the development of cardiac disorders. Typical presentations explained for different kinds of hridroga (cardiac disorders) can be seen in patients. For eg. In vataja hridroga the pain will be severe. It may be cutting, stabbing, tearing etc., in nature. In kaphaja hridrog pain will be minimal. The other symptoms like excessive salivation, heaviness in the chest etc., are more predominant. In pittaja hridroga burning in the sternum/epigastric region is the main presenting feature. The classical treatments mentioned for these individual types of cardiac disorders give an excellent result.		'''Ans''': [[Prakriti]] and the involvement of [[dosha]] are very much influencing the development of cardiac disorders. Typical presentations explained for different kinds of hridroga (cardiac disorders) can be seen in patients. For eg. In vataja hridroga the pain will be severe. It may be cutting, stabbing, tearing etc., in nature. In kaphaja hridrog pain will be minimal. The other symptoms like excessive salivation, heaviness in the chest etc., are more predominant. In pittaja hridroga burning in the sternum/epigastric region is the main presenting feature. The classical treatments mentioned for these individual types of cardiac disorders give an excellent result.
	</div>		</div>

			<big>'''[[Special:ContactMe\|Send us your suggestions and feedback on this page.]]'''</big>

	==References==		==References==

Agnivesha: /* Effect on left ventricular distress */

2021-06-29T09:59:35Z

Effect on left ventricular distress

← Older revision		Revision as of 09:59, 29 June 2021
Line 157:		Line 157:

	====Efficacy in ischemic heart disease====		====Efficacy in ischemic heart disease====
	[[File:Image 3.JPG\|~~500px~~\|'''Image 3: Ischemia Reduction on Myocardial ~~Perfusionthrough~~ SPECT MPI'''\|thumb]]		[[File:Image 3.JPG\|400x400px\|'''Image 3: Ischemia Reduction on Myocardial Perfusion through SPECT MPI'''\|thumb\|alt=]]

	Stress Thallium test was applied to assess the reversal of ischemic changes in patients of CHF associated with myocardial ischemia. The radioactive isotope Thallium was injected into the bloodstream of cardiac patients. Gamma scanner was used to assess the circulation of thallium in the myocardium. After three months of ischemia reversal program, 30.33% of the reduction was observed in ischemia on Myocardial Perfusion		Stress Thallium test was applied to assess the reversal of ischemic changes in patients of CHF associated with myocardial ischemia. The radioactive isotope Thallium was injected into the bloodstream of cardiac patients. Gamma scanner was used to assess the circulation of thallium in the myocardium. After three months of ischemia reversal program, 30.33% of the reduction was observed in ischemia on Myocardial Perfusion

Agnivesha: /* Efficacy in ischemic heart disease */

2021-06-29T09:58:08Z

Efficacy in ischemic heart disease

← Older revision		Revision as of 09:58, 29 June 2021
Line 160:		Line 160:

	Stress Thallium test was applied to assess the reversal of ischemic changes in patients of CHF associated with myocardial ischemia. The radioactive isotope Thallium was injected into the bloodstream of cardiac patients. Gamma scanner was used to assess the circulation of thallium in the myocardium. After three months of ischemia reversal program, 30.33% of the reduction was observed in ischemia on Myocardial Perfusion		Stress Thallium test was applied to assess the reversal of ischemic changes in patients of CHF associated with myocardial ischemia. The radioactive isotope Thallium was injected into the bloodstream of cardiac patients. Gamma scanner was used to assess the circulation of thallium in the myocardium. After three months of ischemia reversal program, 30.33% of the reduction was observed in ischemia on Myocardial Perfusion
	through SPECT MPI.<ref>~~Rohit S~~, Jagdish H, Chandrakant C, Sujit N, Rahul M (2020) Ischemia Reversal Therapy as an add-on Therapy for Ischemic Heart Disease: A Pilot Study based on SPECT Myocardial Perfusion Imaging. J Cardiovasc Dis Diagn 8: 397.</ref>		through SPECT MPI.<ref>Sane R., Jagdish H, Chandrakant C, Sujit N, Rahul M (2020) Ischemia Reversal Therapy as an add-on Therapy for Ischemic Heart Disease: A Pilot Study based on SPECT Myocardial Perfusion Imaging. J Cardiovasc Dis Diagn 8: 397.</ref>

	====Effect on left ventricular distress====		====Effect on left ventricular distress====